Tidal has to its credit, many firsts in the Pharmaceutical Industry in terms of introducing combinations. In fact, Tidal is recognized in the market for ‘concept selling’ skills.

 

Rolosol was the first combination of Diclofenac Potassium and Serratiopeptidase. Rabeflux was a first-time introduction of a rational combination of Rabeprazole and Mosapride in India. Similarly, Hiron Liquid was a unique resin encapsulation technology that masked the metallic taste of carbonyl iron.


Tidal is open to opportunities of partnering for sale and distribution of its products in the Regulated and ROW markets.